Can metoprolol (beta blocker) and lisinopril (angiotensin-converting enzyme inhibitor) be given to a patient with post-myocardial infarction (post-MI) pericarditis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 4, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Post-MI Pericarditis: Beta-Blocker and ACE Inhibitor Use

Yes, both metoprolol and lisinopril should be given to patients with post-MI pericarditis, as the benefits of these guideline-directed therapies for reducing mortality after myocardial infarction outweigh concerns about pericardial inflammation. The key is to use aspirin as first-line therapy for the pericarditis itself while continuing essential post-MI medications.

Beta-Blocker Therapy (Metoprolol)

Beta-blockers must be started and continued indefinitely in all post-MI patients unless contraindicated, regardless of pericarditis presence. 1

  • The ACC/AHA guidelines recommend initiating beta-blocker therapy within the first 24 hours in patients without signs of heart failure, evidence of low-output state, or increased risk for cardiogenic shock 1
  • Beta-blockers should be continued indefinitely in all patients who have had MI, with or without LV dysfunction 1
  • The FDA label for metoprolol demonstrates significant mortality reduction (36% at 3 months) when started early after MI 2

Critical Contraindications to Monitor

Do not give beta-blockers if the patient has: 1

  • Systolic blood pressure <120 mmHg
  • Heart rate >110 bpm at presentation
  • Signs of acute heart failure or cardiogenic shock
  • Evidence of low-output state

ACE Inhibitor Therapy (Lisinopril)

ACE inhibitors should be administered within the first 24 hours to all post-MI patients with anterior location, heart failure, or ejection fraction ≤40%. 1

  • For patients with LVEF <40%, hypertension, diabetes, or heart failure, ACE inhibitors are Class I recommendations and should be continued indefinitely 1
  • Even in patients without these high-risk features, ACE inhibitors are reasonable for all post-MI patients (Class IIa) 1
  • The GISSI-3 trial demonstrated an 11% reduction in mortality at 6 weeks with lisinopril started within 24 hours of MI 3

Dosing Considerations in Post-MI Pericarditis

Start lisinopril at 5 mg within 24 hours, then 5 mg after 24 hours, then 10 mg daily 3

  • If systolic BP <120 mmHg at baseline, start with 2.5 mg 3
  • Reduce dose or discontinue if severe hypotension develops 3

Management of the Pericarditis Component

Aspirin is the preferred first-line therapy for post-MI pericarditis pain, not NSAIDs or corticosteroids. 4, 5, 6

  • Aspirin relieves pericardial discomfort within 48 hours in almost all patients 5
  • NSAIDs should NOT be initiated and should be discontinued during hospitalization for acute coronary syndromes due to increased risk of major adverse cardiac events 1
  • Corticosteroids must be avoided due to reported complications including impaired myocardial healing 4

Clinical Course and Monitoring

Post-MI pericarditis typically develops on day 2-3 after transmural MI and has a benign clinical course 4

  • The presence of pericarditis does not alter the patient's prognosis from the MI itself 4
  • Pericardial effusions occur in up to 28% of post-MI patients but do not absolutely contraindicate anticoagulation 4
  • Most cases resolve with aspirin therapy alone 6

Critical Pitfalls to Avoid

Never withhold beta-blockers or ACE inhibitors solely because of pericarditis presence - the mortality benefit from these medications far exceeds any theoretical concern about pericardial inflammation 1

Do not use NSAIDs (indomethacin, ibuprofen) for pericarditis pain in the acute post-MI setting - these increase risk of MI complications including impaired infarct healing, myocardial rupture, and recurrent ischemic events 1, 4

Avoid corticosteroids - they are associated with increased complications including impaired ventricular remodeling and worse outcomes 4

Practical Treatment Algorithm

  1. Confirm hemodynamic stability - check BP >100 mmHg systolic, HR <110 bpm, no signs of cardiogenic shock 1, 3

  2. Initiate beta-blocker (metoprolol) within 24 hours if hemodynamically stable 1

  3. Start ACE inhibitor (lisinopril) within 24 hours, using reduced dose if BP 100-120 mmHg 1, 3

  4. Treat pericarditis pain with aspirin at doses of 650-1000 mg every 6-8 hours 5, 6

  5. Continue both medications indefinitely as part of guideline-directed medical therapy for secondary prevention 1

The combination of metoprolol and lisinopril with aspirin for pericarditis represents optimal evidence-based care that addresses both the underlying MI and the pericardial complication simultaneously 1, 5.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.